PAVMED INC. (NASDAQ:PAVM) Files An 8-K Results of Operations and Financial Condition
Item 2.02.
| (d) | Exhibits: |
| Exhibit No. | Description |
| 99.1 | Press release. |
PAVmed Inc. Exhibit
EX-99.1 2 ex99-1.htm Exhibit 99.1 PAVmed Provides Business Update and Preliminary Fourth Quarter 2020 Financial Results Announces majority-owned subsidiary Lucid Diagnostics intends to spin-off into a separate public company Lucid Diagnostics to launch major new multi-channel commercialization initiative for its EsoGuard Esophageal DNA Test Conference call to be held today at 8:30 AM EST NEW YORK,…
To view the full exhibit click here
